Feed CVX
CV

Chevron

CVX · NYSE

$205.19 -1.15% (-$2.39)
1M -1.68%
Market Cap $413.5B
P/E Ratio 20.08x
Div. Yield 3.40%
ROE 10.98%

Bulios Fair Price

$103.28

49.7% downside

Current Price

$205.19

Undervalued Fair Value Overvalued

According to Bulios Fair Price, CVX is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
6/9
Valuation
62 /100
Fair
P/E 20.08x
EV/EBITDA 7.93x
P/S 1.98x
Growth
8 /100
Declining
EPS growth 28.69%
Rev. growth 7.85%
FCF growth 23.89%
Profitability
93 /100
Strong
Gross margin 31.00%
Net margin 9.87%
Op. margin 15.83%
Quality
67 /100
Excellent
ROIC 7.69%
ROE 10.98%
ROA 6.24%
Debt
94 /100
Low
Debt/Equity 0.20x
Current ratio 1.36x
Int. coverage 22.46x
Stability
73 /100
Stable
Beta 0.49x
Rev. volatility 7.78%
EPS volatility 12.15%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about CVX
Online

About the company

Chevron (CVX) is a global energy company with a strong position in oil and gas exploration and refining. With over 140 years of experience, Chevron brings innovative and sustainable energy solutions to meet current and future demand. Chevron stock is suitable for investors seeking a stable and long-term investment in the energy sector. Add CVX stock to your watchlist on Bulios and stay informed about the latest events and developments from this leading energy company.

Sector

Energy

Industry

Oil & Gas Integrated

CEO

Michael K. Wirth

Employees

43,039

Headquarters

Houston

Upcoming events

30 OCT

Earnings

Upcoming earnings report

23d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.